Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

بواسطة Aleshin, Alex, Greenberg, Peter L.
الحاوية / القاعدة Blood Adv (2018)

MDS Prognostic Scoring Systems – Past, Present, and Future

بواسطة Jonas, Brian A., Greenberg, Peter L.
الحاوية / القاعدة Best Pract Res Clin Haematol (2014)

Relationship of differential gene expression profiles in CD34(+) myelodysplastic syndrome marrow cells to disease subtype and progression

بواسطة Sridhar, Kunju, Ross, Douglas T., Tibshirani, Robert, Butte, Atul J., Greenberg, Peter L.
منشور في 2009

A phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes

بواسطة Gotlib, Jason, Lavori, Philip, Quesada, Sylvia, Stein, Richard S., Shahnia, Shahin, Greenberg, Peter L.
الحاوية / القاعدة Am J Hematol (2009)

Reduced rRNA expression and increased rDNA promoter methylation in CD34(+) cells of patients with myelodysplastic syndromes

بواسطة Raval, Aparna, Sridhar, Kunju J., Patel, Shripa, Turnbull, Brit B., Greenberg, Peter L., Mitchell, Beverly S.
الحاوية / القاعدة Blood (2012)

Remission Maintenance Therapy in Acute Myelogenous Leukemia

بواسطة Embury, Stephen H., Elias, Laurence, Heller, Philip H., Hood, Charles E., Greenberg, Peter L., Schrier, Stanley L.
منشور في 1977

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

بواسطة Koontz, Michael Zach, Horning, Sandra J., Balise, Raymond, Greenberg, Peter L., Rosenberg, Saul A., Hoppe, Richard T., Advani, Ranjana H.
منشور في 2013

Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

بواسطة Mias, George I., Chen, Rui, Zhang, Yan, Sridhar, Kunju, Sharon, Donald, Xiao, Li, Im, Hogune, Snyder, Michael P., Greenberg, Peter L.
منشور في 2013

Treatment of Higher Risk Myelodysplastic Syndrome Patients Unresponsive to Hypomethylating Agents with ON 01910.Na

بواسطة Seetharam, Mahesh, Fan, Alice C., Tran, Mai, Xu, Liwen, Renschler, John P., Felsher, Dean W., Sridhar, Kunju, Wilhelm, Francois, Greenberg, Peter L.
منشور في 2011

Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms

بواسطة Spinner, Michael A., Aleshin, Alexey, Santaguida, Marianne T., Schaffert, Steven A., Zehnder, James L., Patterson, A. Scott, Gekas, Christos, Heiser, Diane, Greenberg, Peter L.
الحاوية / القاعدة Blood Adv (2020)

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

بواسطة Pang, Wendy W., Pluvinage, John V., Price, Elizabeth A., Sridhar, Kunju, Arber, Daniel A., Greenberg, Peter L., Schrier, Stanley L., Park, Christopher Y., Weissman, Irving L.
منشور في 2013

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

بواسطة Kantarjian, Hagop M., Giles, Francis J., Greenberg, Peter L., Paquette, Ron L., Wang, Eunice S., Gabrilove, Janice L., Garcia-Manero, Guillermo, Hu, Kuolung, Franklin, Janet L., Berger, Dietmar P.
منشور في 2010

Distinct Transcriptomic and Exomic Abnormalities within Myelodysplastic Syndrome Marrow Cells

بواسطة Im, Hogune, Rao, Varsha, Sridhar, Kunju, Bentley, Jason, Mishra, Tejaswini, Chen, Rui, Hall, Jeff, Graber, Armin, Zhang, Yan, Xiao, Li, Mias, George I., Snyder, Michael P, Greenberg, Peter L
الحاوية / القاعدة Leuk Lymphoma (2018)

MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways

بواسطة Youn, Minyoung, Huang, Haigen, Chen, Cheng, Kam, Sharon, Wilkes, Mark C., Chae, Hee-Don, Sridhar, Kunju J., Greenberg, Peter L., Glader, Bertil, Narla, Anupama, Lin, Shuo, Sakamoto, Kathleen M.
الحاوية / القاعدة Blood Adv (2019)

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the E...

بواسطة Greenberg, Peter L., Sun, Zhuoxin, Miller, Kenneth B., Bennett, John M., Tallman, Martin S., Dewald, Gordon, Paietta, Elisabeth, van der Jagt, Richard, Houston, Jessie, Thomas, Mary L., Cella, David, Rowe, Jacob M.
منشور في 2009

Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III...

بواسطة Greenberg, Peter L., Lee, Sandra J., Advani, Ranjana, Tallman, Martin S., Sikic, Branimir I., Letendre, Louis, Dugan, Kathleen, Lum, Bert, Chin, David L., Dewald, Gordon, Paietta, Elisabeth, Bennett, John M., Rowe, Jacob M.
الحاوية / القاعدة J Clin Oncol (2004)

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Le...

بواسطة Prebet, Thomas, Sun, Zhuoxin, Figueroa, Maria E., Ketterling, Rhett, Melnick, Ari, Greenberg, Peter L., Herman, James, Juckett, Mark, Smith, Mitchell R., Malick, Lisa, Paietta, Elisabeth, Czader, Magdalena, Litzow, Mark, Gabrilove, Janice, Erba, Harry P., Gore, Steven D., Tallman, Martin S.
منشور في 2014

A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia

بواسطة Lancet, Jeffrey E., Gojo, Ivana, Gotlib, Jason, Feldman, Eric J., Greer, Jacqueline, Liesveld, Jane L., Bruzek, Laura M., Morris, Lawrence, Park, Youn, Adjei, Alex A., Kaufmann, Scott H., Garrett-Mayer, Elizabeth, Greenberg, Peter L., Wright, John J., Karp, Judith E.
منشور في 2007

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS

بواسطة Barreyro, Laura, Will, Britta, Bartholdy, Boris, Zhou, Li, Todorova, Tihomira I., Stanley, Robert F., Ben-Neriah, Susana, Montagna, Cristina, Parekh, Samir, Pellagatti, Andrea, Boultwood, Jacqueline, Paietta, Elisabeth, Ketterling, Rhett P., Cripe, Larry, Fernandez, Hugo F., Greenberg, Peter L., Tallman, Martin S., Steidl, Christian, Mitsiades, Constantine S., Verma, Amit, Steidl, Ulrich
منشور في 2012

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

بواسطة Fenaux, Pierre, Giagounidis, Aristoteles, Selleslag, Dominik, Beyne-Rauzy, Odile, Mittelman, Moshe, Muus, Petra, Nimer, Stephen D., Hellström-Lindberg, Eva, Powell, Bayard L., Guerci-Bresler, Agnes, Sekeres, Mikkael A., Deeg, H. Joachim, del Cañizo, Consuelo, Greenberg, Peter L., Shammo, Jamile M., Skikne, Barry, Yu, Xujie, List, Alan F.
الحاوية / القاعدة J Hematol Oncol (2017)